BioNexus Gene Lab CFO reports no share ownership
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BioNexus Gene Lab Corp executive Chong Set Fui, the company's CFO, filed an initial statement of beneficial ownership. The filing reports 0 shares of BioNexus Gene Lab Corp common stock owned directly as of 2025-06-17, with no reported purchases, sales, or derivative positions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock | -- | -- | -- |
Key Figures
Key Terms
Common Stock financial
direct_or_indirect regulatory
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does BioNexus Gene Lab Corp's (BGLC) Form 3 show for CFO Chong Set Fui?
Does the BGLC Form 3 report any recent stock purchases or sales by the CFO?
Are any derivative securities reported for the BioNexus Gene Lab (BGLC) CFO on this Form 3?
What type of ownership is reported for the BGLC CFO in this Form 3?
AI-generated analysis. How Rhea-AI works. Not financial advice.